Expression of MRP1 and GSTP1-1 modulate the acute cellular response to treatment with the chemopreventive isothiocyanate, sulforaphane.

Carcinogenesis
Mebrahtu B SibhatuCharles S Morrow

Abstract

A major component of the anticarcinogenic activity of the dietary chemopreventive agent sulforaphane (SFN) is attributed to its ability to induce expression of phase II detoxification genes containing the antioxidant response element (ARE) within their promoters. Because SFN is a reactive electrophile--readily forming conjugates with glutathione (GSH)--we asked whether expression of glutathione S-transferase (GST) P1-1 and the GSH conjugate efflux pump, multidrug resistance or resistance-associated protein (MRP) 1, would significantly modify the cellular response to SFN exposure. This was investigated using GST- and MRP1-poor parental MCF7 cells and transgenic derivatives expressing GSTP1-1 and/or MRP1. Compared with parental cells, expression of GSTP1-1 alone enhanced the rate of intracellular accumulation of SFN and its glutathione conjugate, SFN-SG--an effect that was associated with increased ARE-containing reporter gene induction. Expression of MRP1 greatly reduced SFN/SFN-SG accumulation and resulted in significant attenuation of SFN-mediated induction of ARE-containing reporter and endogenous gene expression. Coexpression of GSTP1-1 with MRP1 further reduced the level of induction. Depletion of GSH prior to SFN treatment...Continue Reading

References

Jul 4, 1990·Journal of the National Cancer Institute·P SkehanM R Boyd
May 13, 1997·Proceedings of the National Academy of Sciences of the United States of America·W W Wasserman, W E Fahl
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·J W FaheyP Talalay
Jul 23, 1999·Toxicological Sciences : an Official Journal of the Society of Toxicology·D L Eaton, T K Bammler
Mar 15, 2001·Proceedings of the National Academy of Sciences of the United States of America·C R Wolf
Aug 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Albena T Dinkova-KostovaPaul Talalay
Oct 3, 2002·Annual Review of Pharmacology and Toxicology·Truyen NguyenCecil B Pickett
Oct 9, 2002·Current Drug Metabolism·Thomas H Rushmore, A-N Tony Kong
Jan 16, 2003·Chest·Richard G Bennett
Mar 27, 2003·Toxicological Sciences : an Official Journal of the Society of Toxicology·Laurie M Zipper, R Timothy Mulcahy
Oct 1, 2003·Molecular and Cellular Biology·Sara B CullinanJ Alan Diehl
Feb 7, 2004·Proceedings of the National Academy of Sciences of the United States of America·Nobunao WakabayashiPaul Talalay
Mar 15, 2005·The Journal of Biological Chemistry·Shivendra V SinghAnna Herman-Antosiewicz
May 31, 2007·American Journal of Physiology. Endocrinology and Metabolism·Subbiah PugazhenthiJawed Alam
Jun 15, 2007·The Journal of Biological Chemistry·Kenta IwasakiYoshiaki Tsuji
Jul 5, 2007·The Journal of Biological Chemistry·Weiping WangJefferson Y Chan
Jul 27, 2007·Molecular Pharmacology·Sally E Purdom-DickinsonQin M Chen

❮ Previous
Next ❯

Citations

Oct 25, 2008·Chemical Society Reviews·Min-Hsiung Pan, Chi-Tang Ho
Jan 27, 2009·Biological Chemistry·Nazzareno BallatoriChristine L Hammond
Dec 20, 2011·Mutation Research·Carmela FimognariPatrizia Hrelia
Oct 12, 2015·Toxicological Sciences : an Official Journal of the Society of Toxicology·Ronald G UdasinJeffrey D Laskin
Feb 3, 2009·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Xiang-Lin Tan, Simon D Spivack
Nov 22, 2017·The Journal of Biological Chemistry·Chen-Shan Chen WoodcockStacy G Wendell
May 31, 2020·Nutrients·Dominika KuranKatarzyna Wiktorska
Oct 2, 2008·Journal of Agricultural and Food Chemistry·Maria Rosecler Miranda RossettoBeatriz Rosana Cordenunsi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.